amiodarone has been researched along with Thrombocytopathy in 1 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berrebi, A | 1 |
| Shtalrid, M | 1 |
| Vorst, EJ | 1 |
1 other study available for amiodarone and Thrombocytopathy
| Article | Year |
|---|---|
Amiodarone-induced thrombocytopathy.
Topics: Amiodarone; Benzofurans; Blood Platelet Disorders; Humans; Male; Middle Aged; Platelet Aggregation | 1983 |